These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26693761)

  • 41. Randomised clinical trial: alginate (Gaviscon Advance) vs. placebo as add-on therapy in reflux patients with inadequate response to a once daily proton pump inhibitor.
    Reimer C; Lødrup AB; Smith G; Wilkinson J; Bytzer P
    Aliment Pharmacol Ther; 2016 Apr; 43(8):899-909. PubMed ID: 26909885
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of alginate in patients with GERD hiatal hernia matters.
    Vardar R; Keskin M; Valitova E; Bayrakci B; Yildirim E; Bor S
    Dis Esophagus; 2017 Oct; 30(10):1-7. PubMed ID: 28859383
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Two placebo-controlled crossover studies in healthy subjects to evaluate gastric acid neutralization by an alginate-antacid formulation (Gaviscon Double Action).
    Wilkinson J; Abd-Elaziz K; den Daas I; Wemer J; van Haastert M; Hodgkinson V; Foster M; Coyle C
    Drug Dev Ind Pharm; 2019 Mar; 45(3):430-438. PubMed ID: 30470147
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Commentary: revisiting the past--does it hold the key to the future treatment of refractory GERD?
    Katz PO; Schnoll-Sussman F
    Aliment Pharmacol Ther; 2013 Jul; 38(2):202-3. PubMed ID: 23772900
    [No Abstract]   [Full Text] [Related]  

  • 45. [Therapeutic procedures in gastroesophageal reflux disease].
    Tytgat GN
    Z Gastroenterol; 1986 Sep; 24 Suppl 2():40-4. PubMed ID: 2877526
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evaluation of the antireflux properties of sodium alginate by means of combined multichannel intraluminal impedance and pH-metry.
    Zentilin P; Dulbecco P; Savarino E; Parodi A; Iiritano E; Bilardi C; Reglioni S; Vigneri S; Savarino V
    Aliment Pharmacol Ther; 2005 Jan; 21(1):29-34. PubMed ID: 15644042
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Commentary: revisiting the past--does it hold the key to the future treatment of refractory GERD? Author's reply.
    Fox M
    Aliment Pharmacol Ther; 2013 Jul; 38(2):203-4. PubMed ID: 23772901
    [No Abstract]   [Full Text] [Related]  

  • 48. Patterns of food and acid reflux in patients with low-grade oesophagitis--the role of an anti-reflux agent.
    Washington N; Steele RJ; Jackson SJ; Washington C; Bush D
    Aliment Pharmacol Ther; 1998 Jan; 12(1):53-8. PubMed ID: 9692701
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Gastroesophageal reflux disease during pregnancy].
    Elokhina TB; Tiutiunnik VL
    Eksp Klin Gastroenterol; 2009; (3):93-7. PubMed ID: 19928006
    [No Abstract]   [Full Text] [Related]  

  • 50. Gaviscon and gastroesophageal reflux in children.
    Buts JP; Leclercq V
    J Pediatr Gastroenterol Nutr; 1987; 6(3):482-3. PubMed ID: 2828595
    [No Abstract]   [Full Text] [Related]  

  • 51. [Restoration of the quality of life by eliminating and prevention of heartburn by alginate: results of multicenter study "VIA APIA"].
    Lazebnik LB; Bordin DS; Masharova AA; Dzhulaĭ GS; Butov MA; Abdulkhakov RA; Eremina EIu; Tarasova LV; Safonova OV; Firsova LD; Kozhurina TS
    Eksp Klin Gastroenterol; 2010; (6):70-6. PubMed ID: 20731169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. An open-label, multicentre study to assess the safety and efficacy of a novel reflux suppressant (Gaviscon Advance) in the treatment of heartburn during pregnancy.
    Lindow SW; Regnéll P; Sykes J; Little S
    Int J Clin Pract; 2003 Apr; 57(3):175-9. PubMed ID: 12723718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment for resilient cough owing to laryngopharyngeal reflux with a combination of proton pump inhibitor and Gaviscon® Advance: how we do it.
    Lieder A; Issing W
    Clin Otolaryngol; 2011 Dec; 36(6):583-7. PubMed ID: 22212545
    [No Abstract]   [Full Text] [Related]  

  • 54. Gaviscon® vs. omeprazole in symptomatic treatment of moderate gastroesophageal reflux. a direct comparative randomised trial.
    Pouchain D; Bigard MA; Liard F; Childs M; Decaudin A; McVey D
    BMC Gastroenterol; 2012 Feb; 12():18. PubMed ID: 22361121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A double-blind controlled trial of 'Gaviscon' in patients with symptomatic gastro-oesophageal reflux.
    Barnardo DE; Lancaster-Smith M; Strickland ID; Wright JT
    Curr Med Res Opin; 1975; 3(6):388-91. PubMed ID: 1183220
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [A successful treatment of gastro-oesophageal reflux in infancy with Gaviscon].
    Gross-Kieselstein E; Branski D; Abrahamov A
    Harefuah; 1975 Oct; 89(7):327-9. PubMed ID: 171200
    [No Abstract]   [Full Text] [Related]  

  • 57. [Gastro-esophageal reflux. Treatment with Gaviscon].
    Ferrier JP; Chevrel B
    Med Chir Dig; 1978; 7(1):73-6. PubMed ID: 642629
    [No Abstract]   [Full Text] [Related]  

  • 58. Clinical and laboratory studies of the antacid and raft-forming properties of Rennie alginate suspension.
    Tytgat GN; Simoneau G
    Aliment Pharmacol Ther; 2006 Mar; 23(6):759-65. PubMed ID: 16556178
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative crossover study on the treatment of heartburn and epigastric pain: Liquid Gaviscon and a magnesium--aluminium antacid gel.
    Chevrel B
    J Int Med Res; 1980; 8(4):300-2. PubMed ID: 6250928
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [In process].
    Vollmer H
    Med Monatsschr Pharm; 2016 Sep; 39(9):396-7. PubMed ID: 29956520
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.